Search

everythinglearnresearchcommunity

for

Search:↓

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

Lowering the dose of cyclosporin caused hair loss that didn't improve even when the dose was increased again.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Targeted testing for telogen effluvium patients can save healthcare costs.

Entospletinib effectively prevents eye and skin GVHD in mice.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.